Billing and Coding: MolDX: Minimal Residual Disease Testing for Solid Tumor Cancers (A58456) - R9 - Effective November 18, 2024

Date Posted: February 10, 2025

This Billing and Coding Article has been revised under contractor numbers: 02101 (AK), 02201 (ID), 02301 (OR), 02401 (WA), 03101 (AZ), 03201 (MT), 03301 (ND), 03401 (SD), 03501 (UT), and 03601 (WY).

Effective Date: November 18, 2024

Summary of Changes:

Under Article Text revised Table 1 row 11 to add "Guardant Reveal (Guardant, Inc) single Plasma Test". This revision is due to covered test that has successfully completed a TA and is effective for 11/18/2024.

Visit the Noridian Molecular Diagnostic Services webpage to view the Active MolDX LCDs or access it via the CMS MCD.

Last Updated $dateUtil.getDate( $modifieddate , "MMM dd , yyyy" , $locale , $tzone )